🧠AI AnalysisViking Therapeutics Advances Weight Loss Drug With Four Phase 3 Trials Underway
Biotech firm Viking Therapeutics is advancing its experimental obesity treatment VK2735 through four Phase 3 trials, aiming to tap into a high-demand market dominated by …